Novavax Announces Submission of Biologics License Application ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Nov. 16, 2021 /PRNewswire-AsiaNet/ -- - SK bioscience submits application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for BLA, to South Korea's MFDSNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-genera...
Authors: LATEST ASIANET NEWS RELEASES